In the recent article by Kim et al., some background information was presented incorrectly. Sentences 2 and 3 of the abstract should read as follows: ''Cysteine protease cathepsin S (CTSS) is involved in inflammatory processes, possibly leading to atherosclerosis and asthma. Recently, it has been reported that CTSS can arouse a predominant sensation of itch accompanied by classical ligand-receptor signaling.'' The authors regret the error.
In Figure 5c , the correct y-axis unit is ''fluorescence intensity (535 nm)'' and not ''OD (578 nm)''. The revised Figure 5c appears below.
The protocol for the protein-binding detection described in the Supplementary Data (Materials and Methods, Solid phase assay) was inexact. The exact procedure is as described here (correction underlined):
Solid phase binding assay
Multiwell plates (96 wells; Dutscher, France) were incubated with 10 mg ml À1 (100 ml per well) of recombinant procollagen V homotrimer or fragment (recombinant N-propeptide) dissolved in 20 mM Na 2 CO 3 pH 9.2, for 18 h at 4 1C. The wells were then blocked with 2% milk powder dissolved in 0.05 M Tris-HCl, pH 7.2, 0.2 M NaCl (Tris buffer solution). Wells were incubated with soluble ligand for 2 h at þ 4 1C and exposed to a constant amount of diluted polyclonal antibodies against laminin-111. Wells were then washed with Tris buffer solution and incubated with appropriate fluorescein isothiocyanate-conjugated secondary antibodies (Jackson Immunoresearch, Beckman Coulter, Roissy, France) for 1 h and fluorescence intensity was determined at 485-535 nm with a VICTOR X4 Technologies reader (Perkin Elmer SAS, Courtaboeuf, France). Negative control values, from wells in which the soluble ligands were omitted, were subtracted from the binding data. 
